Basal-like, HER-2 enriched, luminal A and luminal B) and correlate with
Basal-like, HER-2 enriched, luminal A and luminal B) and correlate with danger of relapse. The progesterone receptor (PR) is expressed in half of sufferers with ER+ breast tumors. Clinical studies…